<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39390039</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>10</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>10</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Racial disparities in Phase 1 COVID-19 vaccine shipments to Neighborhood sites in Pennsylvania by the Federal Retail Pharmacy Program.</ArticleTitle><Pagination><StartPage>23591</StartPage><MedlinePgn>23591</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">23591</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-024-73116-1</ELocationID><Abstract><AbstractText>Early racial disparities in COVID-19 vaccination rates have been attributed primarily to personal vaccine attitudes and behavior. Little attention has been paid to the possibility that inequitable vaccine distribution may have contributed to racial disparities in vaccine uptake when supplies were most scarce. We test the hypothesis that scarce vaccines were distributed inequitably using the shipping addresses of 385,930 COVID-19 vaccine doses distributed in the first 17 weeks of Pennsylvania's Phase 1 rollout (December 14, 2020 through April 12, 2021). All shipments we analyze were allocated via the Federal Retail Pharmacy Program, a public-private partnership coordinated by the Centers for Disease Control and Prevention.Overall, White people had an average of 81.4% more retail pharmacy program doses shipped to their neighborhoods than did Black people. Regression models reveal that weekly vaccine allocations determined by pharmacy chains-rather than initial shipment and administration site decisions requiring state and federal approval-drove these effects. All findings remained consistent after controlling for neighborhood differences in income, population density, insurance coverage, number of pharmacies, and other social determinants of health.Our findings suggest that the private distribution of scarce public resources should be assessed for racial impact, regulated as public resources, and monitored continuously.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Holtzman</LastName><ForeName>Geoffrey S</ForeName><Initials>GS</Initials><AffiliationInfo><Affiliation>, Philadelphia, PA, USA. geoffreyholtzman@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Yukun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Communication Studies, Northeastern University, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Louis</LastName><ForeName>Pierce</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>School of Public Health, Boston University, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>West</LastName><ForeName>Stephen G</ForeName><Initials>SG</Initials><AffiliationInfo><Affiliation>Department of Psychology, Arizona State University, Tempe, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kandaswamy</LastName><ForeName>Piranavakumar</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Computer Science, Boston University, Boston, MA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001741" MajorTopicYN="N">Black or African American</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="Y">COVID-19 Vaccines</DescriptorName><QualifierName UI="Q000600" MajorTopicYN="N">supply &amp; distribution</QualifierName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054625" MajorTopicYN="Y">Healthcare Disparities</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010414" MajorTopicYN="N" Type="Geographic">Pennsylvania</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010594" MajorTopicYN="N">Pharmacies</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012111" MajorTopicYN="Y">Residence Characteristics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000095223" MajorTopicYN="N">White</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>11</Day><Hour>0</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>11</Day><Hour>0</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>10</Day><Hour>23</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39390039</ArticleId><ArticleId IdType="pmc">PMC11466953</ArticleId><ArticleId IdType="doi">10.1038/s41598-024-73116-1</ArticleId><ArticleId IdType="pii">10.1038/s41598-024-73116-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Walks, I. &amp; Ellison, C. Why are Black people being treated like America’s vaccine hesitancy problem? The Philadelphia Inquirer (2021).</Citation></Reference><Reference><Citation>Khubchandani, J. &amp; Macias, Y. COVID-19 vaccination hesitancy in hispanics and African-Americans: A review and recommendations for practice. Brain Behav. Immun. - Health. 15, 100277. 10.1016/j.bbih.2021.100277 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8137342</ArticleId><ArticleId IdType="pubmed">34036287</ArticleId></ArticleIdList></Reference><Reference><Citation>Nuriddin, A., Mooney, G. &amp; White, A. I. R. Reckoning with histories of medical racism and violence in the USA. Lancet. 396 (10256), 949–951 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7529391</ArticleId><ArticleId IdType="pubmed">33010829</ArticleId></ArticleIdList></Reference><Reference><Citation>Washington, H. A. Medical Apartheid: The Dark History of Medical Experimentation on Black Americans from Colonial Times to the Present (Doubleday, 2006).</Citation></Reference><Reference><Citation>Lin, C., Tu, P. &amp; Terry, T. C. Moving the needle on racial disparity: COVID-19 vaccine trust and hesitancy. Vaccine. 40(1), 5–8 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8604693</ArticleId><ArticleId IdType="pubmed">34839990</ArticleId></ArticleIdList></Reference><Reference><Citation>Momplaisir, F. et al. Understanding drivers of coronavirus disease 2019 vaccine hesitancy among blacks. Clin. Infect. Dis.73(10), 1784–1789 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7929035</ArticleId><ArticleId IdType="pubmed">33560346</ArticleId></ArticleIdList></Reference><Reference><Citation>Warren, R. C., Forrow, L., Hodge, D. A. &amp; Truog, R. D. Trustworthiness before trust — COVID-19 vaccine trials and the black community. N. Engl. J. Med.383(22), e121. 10.1056/NEJMp2030033 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">33064382</ArticleId></ArticleIdList></Reference><Reference><Citation>Kricorian, K. &amp; Turner, K. COVID-19 vaccine acceptance and beliefs among Black and Hispanic Americans. PLOS ONE16(8), e0256122. 10.1371/journal.pone.0256122 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8384224</ArticleId><ArticleId IdType="pubmed">34428216</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen, K. H. et al. COVID-19 vaccination intent, perceptions, and reasons for not vaccinating among groups prioritized for early vaccination — United States, September and December 2020. MMWR Morb Mortal. Wkly.70(6), 217–222 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7877585</ArticleId><ArticleId IdType="pubmed">33571174</ArticleId></ArticleIdList></Reference><Reference><Citation>Savoia, E. et al. Predictors of COVID-19 vaccine hesitancy: Socio-demographics, co-morbidity, and past experience of racial discrimination. Vaccines9(7), 767 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8310049</ArticleId><ArticleId IdType="pubmed">34358184</ArticleId></ArticleIdList></Reference><Reference><Citation>Dang, J., King, K. M. &amp; Inzlicht, M. Why are self-report and behavioral measures weakly correlated? Trends Cogn. Sci.24(4), 267–269 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7977810</ArticleId><ArticleId IdType="pubmed">32160564</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen, L. H. et al. Self-reported COVID-19 vaccine hesitancy and uptake among participants from different racial and ethnic groups in the United States and United Kingdom. Nat. Commun.13(1), 636 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8807721</ArticleId><ArticleId IdType="pubmed">35105869</ArticleId></ArticleIdList></Reference><Reference><Citation>Padamsee, T. J. et al. Changes in COVID-19 vaccine hesitancy among black and white individuals in the US. JAMA Netw. Open.5, e2144470. 10.1001/jamanetworkopen.2021.44470 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8783270</ArticleId><ArticleId IdType="pubmed">35061038</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 vaccinations by race/ethnicity data sets. Kaiser Family Foundation. https://www.kff.org/other/state-indicator/covid-19-vaccinations-by-race-ethnicity. Accessed 11 February 2022.</Citation></Reference><Reference><Citation>COVID-19 vaccination demographic trends by report date, national. Centers for Disease Control and Prevention. https://data.cdc.gov/Vaccinations/Archive-COVID-19-Vaccination-Demographic-Trends-by/2vpi-n544 (2022). Accessed 17 January 2023.</Citation></Reference><Reference><Citation>Murthy, B. P. et al. Disparities in COVID-19 vaccination coverage between urban and rural counties — United States, December 14, 2020–April 10, 2021. MMWR Morb Mortal. Wkly. Rep.70(20), 759–764 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8136424</ArticleId><ArticleId IdType="pubmed">34014911</ArticleId></ArticleIdList></Reference><Reference><Citation>Morland, K., Wing, S. &amp; Roux, A. D. The contextual effect of the local food environment on residents’ diets: the atherosclerosis risk in communities study. Am. J. Public. Health. 92(11), 1761–1768 (2002).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1447325</ArticleId><ArticleId IdType="pubmed">12406805</ArticleId></ArticleIdList></Reference><Reference><Citation>Morello-Frosch, R. &amp; Jesdale, B. M. Separate and unequal: residential segregation and estimated cancer risks associated with ambient air toxics in U.S. metropolitan areas. Environ. Health Perspect.114(3), 386–393 (2006).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1392233</ArticleId><ArticleId IdType="pubmed">16507462</ArticleId></ArticleIdList></Reference><Reference><Citation>Suarez, J. J. et al. Food access, chronic kidney disease, and hypertension in the U.S. Am. J. Prev. Med.49(6), 912–920 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4656149</ArticleId><ArticleId IdType="pubmed">26590940</ArticleId></ArticleIdList></Reference><Reference><Citation>Understanding and using American Community Survey data. United States Census Bureau. https://www.census.gov/programs-surveys/acs/library/handbooks/general.html (2020).</Citation></Reference><Reference><Citation>Emanuel, E. J. et al. An ethical framework for global vaccine allocation. Science369(6509), 1309–1312 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691258</ArticleId><ArticleId IdType="pubmed">32883884</ArticleId></ArticleIdList></Reference><Reference><Citation>Fielding, J. et al. Constructing an ethical framework for priority allocation of pandemic vaccines. Vaccine39(5), 797–804 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7779078</ArticleId><ArticleId IdType="pubmed">33408013</ArticleId></ArticleIdList></Reference><Reference><Citation>Jecker, N. S., Wightman, A. G. &amp; Diekema, D. S. Vaccine ethics: An ethical framework for global distribution of COVID-19 vaccines. J. Med. Ethics. 47, 308–317 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33593876</ArticleId></ArticleIdList></Reference><Reference><Citation>Kipnis, P., Soltesz, L., Escobar, G. J., Myers, L. &amp; Liu, V. X. Evaluation of vaccination strategies to compare efficient and equitable vaccine allocation by race and ethnicity across time. JAMA Health Forum. 2(8), e212095. 10.1001/jamahealthforum.2021.2095 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8796992</ArticleId><ArticleId IdType="pubmed">35977198</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 vaccine distribution. Pennsylvania Department of Health. https://www.health.pa.gov/topics/disease/coronavirus/Vaccine/Pages/Distribution.aspx. Accessed 15 February 2022.</Citation></Reference><Reference><Citation>COVID-19 interim vaccination plan v8.0. Pennsylvania Department of Health. https://www.health.pa.gov/topics/Documents/Programs/Immunizations/PA%20Interim%20Vaccine%20Plan%20V.8.pdf (2021). Accessed 11 January 2023.</Citation></Reference><Reference><Citation>Fact sheet: HHS announces ‘HHS Bridge Access Program For COVID-19 Vaccines and Treatments’ to maintain access to COVID-19 care for the uninsured. United States Department of Health and Human Services. https://www.hhs.gov/about/news/2023/04/18/fact-sheet-hhs-announces-hhs bridge-access-program-covid-19-vaccines-treatmentsmaintain-access-covid-19-care-uninsured.html (2023). Accessed 11 August 2023.</Citation></Reference><Reference><Citation>Medicare billing for COVID-19 vaccine shot administration. Centers for Medicare and Medicaid. https://www.cms.gov/medicare/covid-19/medicare-billing-covid-19-vaccineshot-administration. Accessed 18 January 2023.</Citation></Reference><Reference><Citation>COVID-19 vaccination program interim operational guidance jurisdiction operations playbook v2.0. Centers for Disease Control and Prevention. https://www.cdc.gov/vaccines/imz-managers/downloads/COVID-19-Vaccination-Program-Interim_Playbook.pdf (2020). Accessed 11 February 2022.</Citation></Reference><Reference><Citation>Fact sheet: President Biden announces increased vaccine supply, initial launch of the Federal Retail Pharmacy Program, and expansion of FEMA reimbursement to states. White House Briefing Room. https://www.whitehouse.gov/briefing-room/statements-releases/2021/02/02/fact-sheet-president-biden-announces-increased-vaccine-supply-initiallaunch-of-the-federal-retail-pharmacy-program-and-expansion-of-fema-reimbursement-to-states/ (2021). Accessed 17 January 2023.</Citation></Reference><Reference><Citation>Trump administration partners with chain and independent community pharmacies to increase access to future COVID-19 vaccines. HHS Press Office. https://www.hhs.gov/about/news/2020/11/12/trump-administration-partners-chain-independentcommunity-pharmacies-increase-access-future-covid-19-vaccines.html (2020). Accessed January 17 2022.</Citation></Reference><Reference><Citation>COVID-19 vaccination program provider requirements and legal agreement. Pennsylvania Department of Health. https://forms.health.pa.gov/covid-19-provider-agreement-a-b/?stepid=ac98ab6d-232d-ec11-b6e5-001dd800c046&amp;sessionid=0c92fa5b-987a-ef11-a671-001dd8055213. Accessed August 22 2022.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4306458</ArticleId><ArticleId IdType="pubmed">25632292</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 vaccination program interim playbook for jurisdictions operations annex v1.0. Centers for Disease Control and Prevention. https://www.cdc.gov/vaccines/covid-19/downloads/COVID-19-vaccination-program-playbook-annex.pdf. Accessed January 11 2022.</Citation></Reference><Reference><Citation>COVID-19: Efforts to increase vaccine availability and perspectives on initial implementation (GAO-21-443). United States Government Accountability Office. https://www.gao.gov/products/gao-21-443 (2022).</Citation></Reference><Reference><Citation>CDC supplemental COVID-19 vaccine redistribution agreement. Pennsylvania Department of Health. https://forms.health.pa.gov/CDC-COVID-19-Vaccine-Redistribution. Accessed 11 August 2022.</Citation></Reference><Reference><Citation>COVID-19: HHS agencies’ planned reviews of vaccine distribution and communication efforts should include stakeholder perspectives (GAO-22-104457). United States Government Accountability Office. https://www.gao.gov/products/gao-22-104457 (2021).</Citation></Reference><Reference><Citation>Challenges with vaccination data hinder state and local immunization program efforts to combat COVID-19 (OEI-05-22-0010). United States Department of Health and Human Services Office of Inspector General. https://oig.hhs.gov/documents/evaluation/2946/OEI-05-22-00010-Complete%20Report.pdf (2023). Accessed 2 May 2023.</Citation></Reference><Reference><Citation> Early challenges highlight areas for improvement in COVID-19 vaccination programs (OEI-04-21-00190). United States Department of Health and Human Services Office of Inspector General. https://oig.hhs.gov/documents/evaluation/2888/OEI-04-21-00190-Complete%20Report.pdf.</Citation></Reference><Reference><Citation>Simmons, J. P., Nelson, L. D. &amp; Simonsohn, U. False-positive psychology: Undisclosed flexibility in data collection and analysis allows presenting anything as significant. Psychol. Sci.22(11), 1359–1366 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">22006061</ArticleId></ArticleIdList></Reference><Reference><Citation>Munafò, M. R. et al. A manifesto for reproducible science. Nat. Hum. Behav.1(21), 1–9. 10.1038/s41562-016-0021 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7610724</ArticleId><ArticleId IdType="pubmed">33954258</ArticleId></ArticleIdList></Reference><Reference><Citation>Meehl, P. E. Why summaries of research on psychological theories are often uninterpretable. Psychol. Rep.66(1), 195–244 (1990).</Citation></Reference><Reference><Citation>Meehl, P. E. Appraising and amending theories: the strategy of lakatosian defense and two principles that warrant it. Psychol. Inq.1(2), 108–141 (1990).</Citation></Reference><Reference><Citation> CDC/ATSDR social vulnerability index 2018. Centers for Disease Control and Prevention, Agency for Toxic Substances and Disease Registry, Geospatial Research, Analysis, and Services Program. https://www.atsdr.cdc.gov/placeandhealth/svi/data_documentation_download.html. Accessed 18 January 2023.</Citation></Reference><Reference><Citation>Table S1903: Median income in the past 12 months. United States Census Bureau. Accessed 18 January 2023.</Citation></Reference><Reference><Citation>Table B27015: Health insurance coverage status and type by household income in the past 12 months. United States Census Bureau. https://data.census.gov/table/ACSDT5Y2019.B27015?q=Health%20Insurance%20coverage&amp;g=040XX00US42. Accessed 6 April 2023.</Citation></Reference><Reference><Citation>Find naloxone at a pharmacy near me: A listing of known pharmacies in the Commonwealth of Pennsylvania. Open Data PA. https://data.pa.gov/Opioid-Related/Find-Naloxone-at-a-Pharmacy-Near-Me-Current-Statew/ysdx-4vmi/about_data. Accessed 17 March 2024.</Citation></Reference><Reference><Citation>Hume, D. An enquiry concerning human understanding 28–33 (Cambridge University Press, 2007).</Citation></Reference><Reference><Citation> COVID-19: Federal Efforts to Provide Vaccines to Racial and Ethnic Groups.:(GAO-22-105079). United States Government Accountability Office 2022. https://www.gao.gov/products/gao-22-105079</Citation></Reference><Reference><Citation>Tran, P., Tran, L. &amp; Tran, L. The influence of social distancing on COVID-19 mortality in US counties: Cross-sectional study. JMIR Public Health and Surveillance7(3), e21606. 10.2196/21606 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7977611</ArticleId><ArticleId IdType="pubmed">33497348</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaskin, D. J., Zare, H. &amp; Delarmente, B. A. Geographic disparities in COVID-19 infections and deaths: the role of transportation. Transp. Policy. 102, 35–46 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7714661</ArticleId><ArticleId IdType="pubmed">33293780</ArticleId></ArticleIdList></Reference><Reference><Citation>Commute time: All workers should have reasonable commutes. National Equity Atlas. https://nationalequityatlas.org/indicators/Commute_time#/. Accessed 17 February 2023.</Citation></Reference><Reference><Citation>Press, V. G., Huisingh-Scheetz, M. &amp; Arora, V. M. Inequities in technology contribute to disparities in COVID-19 vaccine distribution. JAMA Health Forum2(3), e210264. 10.1001/jamahealthforum.2021.0264 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">36218461</ArticleId></ArticleIdList></Reference><Reference><Citation>Dey, M., Frazis, H., Loewenstein, M. A. &amp; Sun, H. Ability to work from home: evidence from two surveys and implications for the labor market in the COVID-19 pandemic. US Bureau of Labor Statistics. https://www.bls.gov/opub/mlr/2020/article/ability-to-work-from-home.htm (2020). Accessed 22 January 2022,</Citation></Reference><Reference><Citation>Pabilonia, S. W. &amp; Vernon, V. Telework, wages, and time use in the United States. Rev. Econ. Househ.20(3), 687–734 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8879172</ArticleId><ArticleId IdType="pubmed">35250416</ArticleId></ArticleIdList></Reference><Reference><Citation>Workers ages 25 to 54 more likely to telework due to COVID–19 in February 2021. United States Department of Labor. https://www.bls.gov/opub/ted/2021/workers-ages-25-to-54-more-likely-to-telework-due-to-covid-19-in-february-2021.htm (2021).</Citation></Reference><Reference><Citation>Bonilla-Silva, E. Color-blind racism in pandemic times. Sociol. Race Ethn.8(3), 343–354. 10.1177/2332649220941024 (2022).</Citation></Reference><Reference><Citation>Schmidt, H., Gostin, L. O. &amp; Williams, M. A. Is it lawful and ethical to prioritize racial minorities for COVID-19 vaccines? JAMA. 324(20), 2023–2024 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">33052391</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt, H., Shaikh, S. J., Sadecki, E., &amp; Gollust, S. U.S. adults’ preferences for race-based and place-based prioritisation for COVID-19 vaccines. J. Med. Ethics7(48), 497–500 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">34972692</ArticleId></ArticleIdList></Reference><Reference><Citation>Feehan, D. M. &amp; Mahmud, A. S. Quantifying population contact patterns in the United States during the COVID-19 pandemic. Nat. Commun.12(893). 10.1038/s41467-021-20990-2 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7873309</ArticleId><ArticleId IdType="pubmed">33563992</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiti, M. C. et al. Social contact patterns among employees in 3 U.S. companies during early phases of the COVID-19 pandemic, April to June 2020. Epidemics. 36, 100481. 10.1016/j.epidem.2021.100481 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8419109</ArticleId><ArticleId IdType="pubmed">34171510</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldman, N., Pebley, A. R., Lee, K., Andrasfay, T. &amp; Pratt, B. Racial and ethnic differentials in COVID-19-related job exposures by occupational standing in the US. PLoS One16(9), e0256085. 10.1371/journal.pone.0256085 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8409606</ArticleId><ArticleId IdType="pubmed">34469440</ArticleId></ArticleIdList></Reference><Reference><Citation>Enayati, S. &amp; Özaltın, O. Y. Optimal influenza vaccine distribution with equity. Eur. J. Oper. Res.283, 71–725 (2020).</Citation></Reference><Reference><Citation>Vitoriano, B., Ortuño, M. T., Tirado, G. &amp; Montero, J. A multi-criteria optimization model for humanitarian aid distribution. J. Glob Optim.51, 189–208 (2011).</Citation></Reference><Reference><Citation>Yee, V., Bajaj, S. S. &amp; Stanford, F. C. Building a pandemic supply chain — equity over equality. Nat. Med.28(4), 609–610 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9907003</ArticleId><ArticleId IdType="pubmed">35288699</ArticleId></ArticleIdList></Reference><Reference><Citation>Texas announces COVID-19 vaccination hub providers for week of Jan. 11. Texas Department of Health and Human Services. https://dshs.texas.gov/news/releases/2021/20210110.aspx (2021). Accessed 16 January 2022.</Citation></Reference><Reference><Citation>Holtzman, G. S., Khoshkoo, N. A. &amp; Nsoesie, E. O. The Racial Data Gap: Lack of Racial Data as a Barrier to Overcoming Structural Racism. The American Journal of Bioethics. 22(3), 39–42. 10.1080/15265161.2022.2027562 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35258425</ArticleId></ArticleIdList></Reference><Reference><Citation>Operation Warp Speed: Accelerated COVID-19 vaccine development status and efforts to address manufacturing challenges (GAO-21-319). United States Government Accountability Office. https://www.gao.gov/products/gao-21-319 (2021).</Citation></Reference><Reference><Citation>COVID-19: HHS and DOD transitioned vaccine responsibilities to HHS, but need to address outstanding issues (GAO-22-104453). United States Government Accountability Office. https://www.gao.gov/products/gao-22-104453 (2022).</Citation></Reference><Reference><Citation>HHS commercialization transition guide: Sunsetting the U.S. government COVID-19 vaccine distribution program. Centers for Disease Control and Prevention. https://www.cdc.gov/vaccines/covid-19/downloads/HHS-Commercialization-Transition-Guide-508.pdf (2023).</Citation></Reference><Reference><Citation>United States COVID-19 cases and deaths by state over time data sets. Centers for Disease Control and Prevention. https://data.cdc.gov/Case-Surveillance/United-States-COVID-19-Cases-and-Deaths-by-State-o/9mfq-cb36.</Citation></Reference><Reference><Citation>Table DP05: ACS demographic and housing estimates. United States Census Bureau. https://data.census.gov/table?q=DP05&amp;g=0400000US42. Accessed 18 January 2023.</Citation></Reference><Reference><Citation>Hickman, C. B. The devil and the one drop rule: Racial categories, African Americans, and the U.S. Census. Michigan Law Review95, 1161 (1997).</Citation></Reference><Reference><Citation>Little, R. J. A. &amp; Rubin, D. B. Statistical Analysis with Missing Data. 3rd edn. (Wiley, 2019).</Citation></Reference><Reference><Citation>Meehl, P. E. When shall we use our heads instead of the formula? J. Couns. Psychol.4(4), 268–273 (1957).</Citation></Reference><Reference><Citation>Cohen, J., Cohen, P., West, S. G. &amp; Aiken, L. S. Applied Multiple Regression/Correlation Analysis for the Behavioral Sciences 3rd edn. (L. Erlbaum Associates, 2003).</Citation></Reference><Reference><Citation>Hosmer, D. W. Jr, Lemeshow, S. &amp; Sturdivant, R. X. Applied Logistic Regression 3rd edn. (Wiley, 2013).</Citation></Reference><Reference><Citation>Bursac, Z., Gauss, C. H., Williams, D. K. &amp; Hosmer, D. W. Purposeful selection of variables in logistic regression. Source Code Biol. Med.3(17). 10.1186/1751-0473-3-17 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2633005</ArticleId><ArticleId IdType="pubmed">19087314</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark, L. P., Millet, D. B. &amp; Marshall, J. D. National patterns in environmental injustice and inequality: Outdoor NO2 Air Pollution in the United States. PLOS ONE9(4), e94431. 10.1371/journal.pone.0094431 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3988057</ArticleId><ArticleId IdType="pubmed">24736569</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmerman, F. J. &amp; Anderson, N. W. Trends in health equity in the United States by race/ethnicity, sex, and income, 1993–2017. JAMA Netw. Open.2(6), e196386. 10.1001/jamanetworkopen.2019.6386 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6604079</ArticleId><ArticleId IdType="pubmed">31251377</ArticleId></ArticleIdList></Reference><Reference><Citation>Bland, J. M. &amp; Kerry, S. M. Weighted comparison of means. BMJ. 316(7125), 129 (1998).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2665397</ArticleId><ArticleId IdType="pubmed">9462320</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahneman, D. Control of spurious association and the reliability of the controlled variable. Psychol. Bull.64(5), 326–329 (1965).</Citation><ArticleIdList><ArticleId IdType="pubmed">5851540</ArticleId></ArticleIdList></Reference><Reference><Citation>Spector, P. E. &amp; Brannick, M. T. Methodological Urban legends: The misuse of statistical control variables. Organizational Res. Methods. 14(2), 287–305 (2011).</Citation></Reference><Reference><Citation>Lee, J. Odds ratio or relative risk for cross-sectional data? Int. J. Epidemiol.23(1), 201–203 (1994).</Citation><ArticleIdList><ArticleId IdType="pubmed">8194918</ArticleId></ArticleIdList></Reference><Reference><Citation>Pearce, N. Effect measures in prevalence studies. Environemental Health Perspect.112(10), 1047–1050 (2004).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1247374</ArticleId><ArticleId IdType="pubmed">15238274</ArticleId></ArticleIdList></Reference><Reference><Citation>Meehl, P. E. Nuisance variables and the ex post facto design. In Minnesota studies in the philosophy of science. Vol. IV. Analyses of theories and methods of physics and psychology (eds. Radner, M. &amp; Winokur, S.) 373–402 (University of Minnesota Press, 1970).</Citation></Reference><Reference><Citation>Coxe, S., West, S. G. &amp; Aiken, L. S. The analysis of count data: a gentle introduction to poisson regression and its alternatives. J. Pers. Assess.91(2), 121–136 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">19205933</ArticleId></ArticleIdList></Reference><Reference><Citation>Barros, A. J. &amp; Hirakata, V. N. Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med. Res. Methodol.3(1), 21. 10.1186/1471-2288-3-21 (2003).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC521200</ArticleId><ArticleId IdType="pubmed">14567763</ArticleId></ArticleIdList></Reference><Reference><Citation>Bleser, W. K., Young, S. I. &amp; Miranda, P. Y. Disparities in patient- and family-centered care during US children’s health care encounters: a closer examination. Acad. Pediatr.17(1), 17–26 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6333206</ArticleId><ArticleId IdType="pubmed">27422496</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, J. &amp; Yu, K. F. What’s the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA280(19), 1690–1691 (1998).</Citation><ArticleIdList><ArticleId IdType="pubmed">9832001</ArticleId></ArticleIdList></Reference><Reference><Citation>McNutt, L. A., Wu, C., Xue, X. &amp; Hafner, J. P. Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am. J. Epidemiol.157(10), 940–943 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12746247</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson, M. L., Myers, J. E. &amp; Kriebel, D. Prevalence odds ratio or prevalence ratio in the analysis of cross sectional data: What is to be done? Occup. Environ. Med.55(4), 272–277 (1998).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1757577</ArticleId><ArticleId IdType="pubmed">9624282</ArticleId></ArticleIdList></Reference><Reference><Citation>Greves Grow, H. M. et al. Child obesity associated with social disadvantage of children’s neighborhoods. Soc. Sci. Med.71(3), 584–591 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2928553</ArticleId><ArticleId IdType="pubmed">20541306</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan, W. H., Evers, E. R. K. &amp; Moore, D. A. Poisson regressions: a little fishy. Collabra: Psychol.7(1), 27242. 10.1525/collabra.27242 (2021).</Citation></Reference><Reference><Citation>Hilbe, J. M. Negative Binomial Regression 2nd edn. (Cambridge University Press, 2011).</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>